Neuroendocrine and metabolic aspects of functional hypothalamic amenorrhea

Archives of Perinatal Medicine

Volumn 18, Issue 2, 2012, Pages 76-80

  Meczekalski, Błazej ^a   Podfigurna stopa, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bone loss; Cardiovascular system; Corticotropin releasing hormone; Functional hypothalamic amenorrhea; Kisspeptin

Indexed keywords

EID: 84867407379     PISSN: 15050580     EISSN: 15084868     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Marshall L.A. (1994) Clinical evaluation of amenorrhea in active and athletic women. Clin. Sports Med. 13: 371-387.
2. Yen S.S. (1998) Effects of lifestyle and body composition on the ovary. Endocrinol. Metab. Clin. North Am. 27: 915-926.
3. Meczekalski B., Podfigurna-Stopa A., Warenik-Szymankiewicz A., Genazzani A.R. (2008) Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol. Endocrinol. 24: 4-11.
4. Schally A.V., Arimura A., Baba Y. et al. (1971) Isolation and properties of the FSH and LH-releasing hormone. Biochem. Biophys. Res. Commun. 43: 393-399.
5. Clarke I.J. (1987) Control of GnRH secretion. J. Reprod. Fertil. Suppl. 34: 1-8.
6. Meczekalski B., Genazzani A.R., Genazzani A.D. et al. (2006) Clinical evaluation of patients with weight loss-related amenorrhea: neuropeptide Y and luteinizing hormone pulsatility. Gynecol. Endocrinol. 22: 239-43.
7. Vale W., Spiess J., Rivier C., Rivier J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and b-endorphin. Science 213: 1394-1397.
8. Grino M., Chrousos G.P., Margioris A.N. (1987) The corticotropin releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commun. 148(3): 1208-1214.
9. Smith R., Nicholson R.C. (2007) Corticotropin releasing hormone and the timing of birth. Front. Biosci. 12: 912-918.
10. Petraglia F., Sutton S., Vale W., Plotsky P. (1987) Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 120: 1083-1088.
11. Rivier C., Rivier J., Vale W. (1986) Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231: 607-609.
12. Genazzani A.D., Petraglia F., Volpe A., Genazzani A.R. (1997) Hypothalamic amenorrhea: neuroendocrine mechanisms/ stress-induced anomalies. Assist. Reprod. Technol/ Androl. 9: 1-13.
13. Rivier C., Rivier J., Vale W. (1986) Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231: 607-609.
14. Berga S.L., Loucks-Daniels T.L., Adler L.J. (2000) Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea. Am. J. Obstet. Gynecol. 182: 776-781.
15. Oswiecimska J., Ziora K., Geisler G., Broll-Wastka K. (2005) Prospective evaluation of leptin and neuropeptide Y (NPY) serum levels in girls with anorexia nervosa. Neuro. Endocrinol. Lett. 26: 301-304.
16. Mastorakos G., Scopa C.D., Vryonidou A. et al. (1994) Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191-1197.
17. Genazzani A.D., Luisi M., Malavasi B. et al. (2002) Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur. J. Endocrinol. 146: 347-356.
18. Biller B.M., Federoff H.J., Koenig J.I., Klibanski A. (1990) Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 70: 311-317.
19. Lee J.H., Miele M.E., Hicks D.J. et al. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. 88(23), 1731-7.
20. Kotani M., Detheux M., Vandenbogaerde A. et al. (2001) The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 276, 34631-6.
21. Nash K.T., Phadke P.A., Navenot J.M. et al. (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J. Natl. Cancer Inst. 99(4), 309-21.
22. Funes S., Hedrick J.A., Vassileva G. et al. (2003) The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem. Biophys. Res. Commun. 312(4), 1357-63.
23. Meczekalski B., Podfigurna-Stopa A., Genazzani A.R. (2011) Why kisspeptin is such important for reproduction? Gynecol. Endocrinol. 27: 8-13.
24. Ohtaki T., Shintani Y., Honda S. et al. (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411(6837), 613-7.
25. Castellano J.M., Navarro V.M., Fernández-Fernández R. et al. (2005) Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146(9), 3917-25.
26. Sowers M.F. (2000) Lower peak bone mass and its decline. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 14: 317-29.
27. Seeman E. (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850.
28. Rigotti N.A., Neer R.M., Skates S.J. et al. (1991) The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 265: 1133-8.
29. Imai Y., Youn M.Y., Kondoh S. et al. (2009) Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann. NY Acad. Sci. 1173 Suppl. 1: E31-9.
30. Gibson J.H., Mitchell A., Harries M.G., Reeve J. (2004) Nutritional and exercise-related determinants of bone density in elite female runners. Osteoporos. Int. 15: 611-8.
31. Warren M.P., Brooks-Gunn J., Fox R.P. et al. (2002) Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J. Clin. Endocrinol. Metab. 87: 3162-8.
32. Warren M.P., Chua A.T. (2008) Exercise-induced amenorrhea and bone health in the adolescent athlete. Ann. NY Acad. Sci. 1135: 244-52.
33. Podfigurna-Stopa A., Pludowski P., Jaworski M. et al. (2012) Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Gynecol. Endocrinol. 28: 299-304.
34. Cárdenas Morales B.E., Pérez Campos E. (2003) Bibliographic review. The role of hypoestrogenism in postmenopausal osteoporosis - new perspectives. Ginecol. Obstet. Mex. 71: 187-94.
35. Gibson J.H., Mitchell A., Harries M.G., Reeve J. (2004) Nutritional and exercise-related determinants of bone density in elite female runners. Osteoporos. Int. 15: 611-8.
36. Norian J.M., Zeitlian G., Adel G. et al. (2009) Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance? Fertil. Steril. 91: 542-8.
37. Jayasinghe Y., Grover S.R., Zacharin M. (2008) Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG 115: 304-315.
38. Meczekalski B., Podfigurna-Stopa A., Genazzani A.R. (2010) Hypoestrogenism in young women and its influence on bone mass density. Gynecol. Endocrinol. 26: 652-7.
39. Misra M., Aggarwal A., Miller K.K. (2004) Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114:1574-83.
40. Lawson E.A., Donoho D., Miller K.K. et al. (2009) Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J. Clin. Endocrinol. Metab. 94: 4710-6.
41. Taylor H.S., Cass I., Lang R. (1996) Bone loss in Kallmann syndrome. Obstet. Gynecol. 88: 734.
42. Gordon C.M., Grace E., Emans S.J. et al. (2002) Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J. Clin. Endocrinol. Metab. 87: 4935-41.
43. Fenichel R.M., Warren M.P. (2007) Anorexia, bulimia, and the athletic triad: evaluation and management. Curr. Osteoporos. Rep. 5: 160-4.
44. Otis C.L., Drinkwater B., Johnson M. et al. (1997) American College of Sports Medicine position stand. The female athlete triad. Med. Sci. Sports Exerc. 29(5): i-ix.
45. Burrows M., Shepherd H., Bird S. et al. (2007) The components of the female athlete triad do not identify all physically active females at risk. J. Sports Sci. 25: 1289-97.
46. Nattiv A., Loucks A.B., Manore M.M. et al. (2007) American College of Sports Medicine. American College of Sports Medicine position stand. The female athlete triad. Med. Sci. Sports Exerc. 39: 1867-82.
47. Di Carlo C., Di Spiezio Sardo A., Bifulco G. et al. (2007) Postmenopausal hypoestrogenism increases vasoconstrictor neuropeptides and decreases vasodilator neuropeptides content in arterial-wall autonomic terminations. Fertil. Steril. 88: 95-9.
48. Soleimany G., Dadgostar H., Lotfian S. et al. (2012) Bone Mineral Changes and Cardiovascular Effects among Female Athletes with Chronic Menstrual Dysfunction. Asian J. Sports Med. 3: 53-8.
49. O'Donnell E., Goodman J.M., Harvey P.J. (2011) Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. J. Clin. Endocrinol. Metab. 96: 3638-48.
50. Yoshida N., Ikeda H., Sugi K., Imaizumi T. (2006) Impaired endothelium-dependent and independent vasodilation in young female athletes with exercise-associated amen